Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FXJHL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,223
Award facts
- Contract value 100% obligated
- $6,223.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,223.32 to AmerisourceBergen Drug Corp on May 30, 2025, for RINVOQ ER 15 mg tablets (30-count units), with final delivery scheduled for June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This specific delivery order for RINVOQ ER—a JAK inhibitor used to treat rheumatoid arthritis and other inflammatory conditions—exemplifies the company's role in supplying specialized pharmaceutical commodities to support military medical readiness and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FXJHL?
SPE2DB25FXJHL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FXJHL worth?
The government has obligated $6,223 on SPE2DB25FXJHL.
Is contract SPE2DB25FXJHL an order under another contract?
Yes. SPE2DB25FXJHL is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXJHL competed?
The extent of competition for SPE2DB25FXJHL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award